SCHEMBL7748262

SCHEMBL7748262

COCCOc1cc(C)nc2c(OCc3c(Cl)ccc([N+](=O)[O-])c3Cl)cccc12

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RORC P51449 9/20 0.46
BDKRB2 P30411 8/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6639746 0.91 BDKRB2 (0.48) RORCBDKRB2MEN1KMT2A
SCHEMBL7749686 0.90 BDKRB2 (0.49) RORCBDKRB2
SCHEMBL7747421 0.89 RORC (0.45) RORCBDKRB2
SCHEMBL6644732 0.88 RORC (0.49) RORCBDKRB2KMT2A
SCHEMBL7748383 0.87 BDKRB2 (0.51) RORCBDKRB2
SCHEMBL7747963 0.86 RORC (0.47) RORCBDKRB2MEN1KMT2A
SCHEMBL7748533 0.85 RORC (0.47) RORCBDKRB2
SCHEMBL7840252 0.83 RORC (0.46) RORCBDKRB2MEN1KMT2A
SCHEMBL7842267 0.83 BDKRB2 (0.51) RORCBDKRB2
SCHEMBL7747994 0.80 NPC1 (0.45) RORCBDKRB2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0622361-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-10-04 EP disclosed
US-6169095-B1 FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES IN THE EYE, SUCH AS ALLERGY, INFLAMMATION AND PAIN OF THE EYE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
US-5922711-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, SHOCK OR ANALGESICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-07-13 US disclosed
US-5708173-A PREPARATION OF SUBSTITUTED QUINOLINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-13 US disclosed
US-5563162-A CAN BE ADMINISTERD FOR THE TREATMENT OF ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASES, SHOCK OR PAIN IN ANIMALS AND HUMANS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-08 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed